Services

AI gives you the power to redesign health services

At Skin Analytics we know that a high quality AI needs to be carefully built into existing and new health pathways. 

Harnessing the power of DERM means that we can help to deliver dermatology services that improve a patient’s ability to access skin cancer assessments and reduce costs to the health system

Improving Access

  • Delayed access to medical care can reduce patient outcomes.
  • We provide healthcare professionals with a simple to use service that is easily completed within their consultation times.
  • DERM can be used anywhere that there is mobile phone or internet coverage helping to improve patient pathways for people living in remote regions.

Reducing Costs

  • We enable GPs or other healthcare professionals to better identify skin cancers that need onward referral to specialist.
  • Through reduced referral rates DERM reduces the need for specialist appointments for skin cancer.

DERM Skin Cancer Triage in the NHS

Every year 470,000 patients are placed on the ‘Urgent 2 week wait’ treatment pathway to find only 16,000 melanoma. Demand is growing while capacity is not.

DERM identifies malignant skin lesions with high levels of sensitivity and specificity. This technology helps reduce the need for secondary care referrals.

University Hospitals Birmingham NHS Trust’s skin cancer community assessment service is using the Skin Analytics platform to safely reduce delays in skin cancer detection and treatment.

Additionally, Skin Analytics provides skin cancer teledermatology services to CCG’s to reduce secondary care referrals. 

Improving customer access with partners

Vitality

We’ve been working with Vitality since 2015 to allow their members to get a skin check within a few days from the comfort of their own home. We send special imaging kits to patients who capture images of the lesions they’re concerned about for review by our consultant dermatologists. Patients are either re-assured by us, or referred on for a face to face appointment with a dermatologist by Vitality.

Bupa

In 2020 we launched a new pathway with Bupa, to enable their members to access high quality skin checks from the comfort of their own home. You can find more about this here.

Patient Safety and Quality Policy

Skin Analytics aims to provide best in class solutions for patients. We work to meet our customers and partners expectations by delivering on our brand vision with innovative and customer focused products and services.

We empower our teams to maintain a culture of innovation and continuous improvement, underpinned by an effective and efficient Quality Management System that complies with statutory and regulatory requirements.

We put safety and outcomes at the heart of what we do, to provide high quality products and services which are reliable, safe and compliant which is why we are so proud to have achieved ISO 13485:2016 compliance. 

Partner with us

 

  • Our services are only available through our clinical partners in the UK. If you're worried about your skin and haven't been referred to us please speak to a doctor without delay.

 

Patient Safety and Quality Policy

Skin Analytics aims to provide best in class solutions for patients. We work to meet our customers and partners expectations by delivering on our brand vision with innovative and customer focused products and services.

We empower our teams to maintain a culture of innovation and continuous improvement, underpinned by an effective and efficient Quality Management System that complies with statutory and regulatory requirements.

We put safety and outcomes at the heart of what we do, to provide high quality products and services which are reliable, safe and compliant which is why we are so proud to have achieved ISO 13485:2016 compliance. MD 711728. 

Clinical Advisory Committee

Professor Scott Kitchnener

Professor Scott Kitchnener

Committee Chair. Primary Care Medical Service Director

Scott is a qualified specialist in medical leadership and management (FRACMA), a graduate of the AICD, a specialist public health physician (FAFPHM), while remaining a clinician with specialist standing as a general practitioner in rural practice. He has experience in health and education corporate governance and leadership in the private sector, public sector, higher education sector, international and Australian biotech sectors and in the military. His on-going research and experience have been in addressing health issues of developing nations, rural health and workforce, and particularly preventive approaches to public health challenges. 

Dr Niall Wilson

Dr Niall Wilson

Consultant Dermatologist

Niall qualified in Medicine from the University of Liverpool in 1991. He has been an NHS Consultant Dermatologist since 2000. He has special interests in skin cancer, hyperhidrosis and skin disorders in immunosuppressed patients. He has also been involved with postgraduate education for many years and is currently vice chair of the Specialist Advisory Committee for Dermatology, which oversees Dermatology training in the UK.

Dr Lucy Thomas

Dr Lucy Thomas

Consultant Dermatologist

Lucy is a Consultant Dermatologist at the Phoenix Hospital Group in London.

Professor Chris Hyde

Professor Chris Hyde

Health Economics

Chris is a professor of Public Health and Clinical Epidemiology at Exeter University. He is a School lead for research on test evaluation including systematic reviews, economic models and primary research. He leads the Exeter Test Group and is the diagnostics theme lead for PenCLAHRC. He is part of the Peninsula Technology Assessment Group (PenTAG). He directed the team delivering health technology assessments for national policy-making bodies, particularly NICE, from 2009 until 2015 and continues to support it by being the lead on HTAs of tests and through membership of its steering group. He is a long standing member of NICE's Diagnositc Advisory Committee and recently joined the National Screening Committee.

Justin M Ko, MD, MBA

Justin M Ko, MD, MBA

CLINICAL ASSOCIATE PROFESSOR, DERMATOLOGY STANFORD UNIVERSITY

Dr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department's efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including co-chairing the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care’s Ambulatory clinics, and as a Service Medical Director.

His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artifical intelligence to increase the breadth of populations that can be reached. He chairs the American Academy of Dermatology's Task Force Committee on Augmented Intelligence.